The lack of NK and CD8 + T cells within the TME characterizes colon cancer as a cold tumor so there may be a beneficial effect for immune stimulants that are combined with chemotherapy, so that is challenged by toxic drug becomes a hot tumor when it is infiltrated by active immune effector cells [17,24]. This evidence concerns the gene CD8A and neoplasm.